(Q34487146)

2 August 2017

1 reference

title

A novel approach to defining the relationship between lung function and symptom status in asthma (English)

1 reference

2 August 2017

1 reference

4

A David Paltiel

1 reference

2 August 2017

Karen M Kuntz

1

1 reference

2 August 2017

Barrett T Kitch

series ordinal

2

1 reference

2 August 2017

Anne L Fuhlbrigge

series ordinal

3

1 reference

2 August 2017

Scott T Weiss

series ordinal

5

1 reference

2 August 2017

language of work or name

1 reference

1 January 2002

1 reference

Journal of Clinical Epidemiology

2 August 2017

published in

1 reference

2 August 2017

volume

55

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

11-18

1 reference

Physiologic measures: pulmonary function tests. Asthma outcome

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Spirometry in the Lung Health Study. 1. Methods and quality control.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

The cost-effectiveness of preventing AIDS-related opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Fluticasone propionate compared with theophylline for mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900412-7

7 January 2021

10.1016/S0895-4356(01)00412-7

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yjyhxanqaba55o4t36fc6y5pxa

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_yjyhxanqaba55o4t36fc6y5pxa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yjyhxanqaba55o4t36fc6y5pxa

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/yjyhxanqaba55o4t36fc6y5pxa

1 reference

30 July 2022